Get the Stockscreener App
12.91
0.54%
-0.07
Pre-market:
12.51
-0.40
-3.10%
Beta Bionics Inc stock is traded at $12.91, with a volume of 1.36M.
It is down -0.54% in the last 24 hours and up +20.65% over the past month.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
See More
Previous Close:
$12.98
Open:
$13.1
24h Volume:
1.36M
Relative Volume:
1.15
Market Cap:
$575.29M
Revenue:
$100.25M
Net Income/Loss:
$-73.20M
P/E Ratio:
-7.6873
EPS:
-1.6794
Net Cash Flow:
$-56.22M
1W Performance:
+21.45%
1M Performance:
+20.65%
6M Performance:
-36.22%
1Y Performance:
+15.89%
1-Day Range:
$12.79
$13.35
1-Week Range:
$10.50
$13.35
52-Week Range:
$8.80
$32.71
Beta Bionics Inc Stock (BBNX) Company Profile
Name
Beta Bionics Inc
Sector
Industry
Phone
949-427-7785
Address
11 HUGHES, IRVINE
Compare BBNX vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BBNX
Beta Bionics Inc
|
12.91 | 578.41M | 100.25M | -73.20M | -56.22M | -1.6794 |
ABT
Abbott Laboratories
|
96.00 | 168.22B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
338.34 | 131.49B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
85.00 | 110.66B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
60.99 | 95.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.44 | 46.69B | 6.07B | 1.06B | 1.34B | 1.8063 |
Beta Bionics Inc Stock (BBNX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-09-26 | Initiated | UBS | Buy |
| Jan-27-26 | Initiated | TD Cowen | Hold |
| Jan-09-26 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-21-25 | Resumed | Stifel | Buy |
| Oct-01-25 | Upgrade | Goldman | Neutral → Buy |
| Jun-16-25 | Initiated | Truist | Buy |
| Jun-12-25 | Initiated | Lake Street | Buy |
| May-30-25 | Initiated | Goldman | Neutral |
| May-30-25 | Initiated | Wolfe Research | Outperform |
| Feb-24-25 | Initiated | BofA Securities | Buy |
| Feb-24-25 | Initiated | Lake Street | Buy |
| Feb-24-25 | Initiated | Leerink Partners | Outperform |
| Feb-24-25 | Initiated | Piper Sandler | Overweight |
| Feb-24-25 | Initiated | Stifel | Buy |
| Feb-20-25 | Initiated | Ladenburg Thalmann | Neutral |
| Feb-20-25 | Initiated | Robert W. Baird | Neutral |
View All
Beta Bionics Inc Stock (BBNX) Latest News
Beta Bionics, Inc. (BBNX) soars 10.3%: Is further upside left in the stock? - MSN
Beta Bionics Inc (BBNX) Q1 2026 Earnings Report Preview: What To Expect - GuruFocus
Midday Stock Roundup: LoanDepot Shares Jump 15% - Orange County Business Journal
Beta Bionics (NASDAQ:BBNX) Trading Down 4.9% Following Analyst Downgrade - MarketBeat
Beta Bionics, Inc. (BBNX) Soars 10.3%: Is Further Upside Left in the Stock? - Yahoo Finance
Earnings Preview: Beta Bionics to Report Financial Results Post-market on April 21 - 富途牛牛
Truist Financial Lowers Beta Bionics (NASDAQ:BBNX) Price Target to $18.00 - MarketBeat
Beta Bionics (NASDAQ:BBNX) Trading Up 8.3%What's Next? - MarketBeat
Beta Bionics, Inc. Investigated by the Portnoy Law Firm - GlobeNewswire
BBNX Options Chain — NASDAQ:BBNX - TradingView
BBNX Options Volatility — NASDAQ:BBNX - TradingView
Short Covering: Is Beta Bionics Inc exposed to currency risks2026 Biggest Moves & Community Shared Stock Ideas - baoquankhu1.vn
Companies Like Beta Bionics (NASDAQ:BBNX) Are In A Position To Invest In Growth - Sahm
[ARS] Beta Bionics, Inc. SEC Filing - Stock Titan
Executive pay and board elections at Beta Bionics (NASDAQ: BBNX) 2026 meeting - Stock Titan
Artificial Pancreas System Market to Hit US$ 2,070.82 Million - openPR.com
Goldman Sachs Maintains Beta Bionics(BBNX.US) With Buy Rating, Cuts Target Price to $20 - Moomoo
Stock Recap: Whats the RSI of Beta Bionics Inc stockSwing Trade & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Activity Recap: Does Beta Bionics Inc have pricing powerTrade Performance Summary & Weekly Hot Stock Watchlists - baoquankhu1.vn
Volume Report: Can Beta Bionics Inc deliver alphaIndex Update & Trade Opportunity Analysis - baoquankhu1.vn
Beta Bionics 2-Year Revenue Jumps 736% to $103.2 Million - Orange County Business Journal
JPMorgan Chase Boosts Stake in Beta Bionics - National Today
JPMorgan Chase & Co. Raises Stock Position in Beta Bionics, Inc. $BBNX - MarketBeat
SG Americas Securities LLC Acquires New Position in Beta Bionics, Inc. $BBNX - MarketBeat
Here's Why We're Not Too Worried About Beta Bionics' (NASDAQ:BBNX) Cash Burn Situation - 富途牛牛
Beta Bionics Introduces Bionic Insights™ in Bionic ReportsTransforming How Clinicians Understand and Optimize Diabetes Care - The Manila Times
Beta Bionics Introduces Bionic Insights in Bionic Reports — Transforming How Clinicians Understand and Optimize Diabetes Care - 富途牛牛
Beta Bionics Receives 'Moderate Buy' Consensus from Analysts - National Today
Beta Bionics, Inc. (NASDAQ:BBNX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Beta Bionics to Announce First Quarter 2026 Financial Results on April 21, 2026 - The Manila Times
Beta Bionics to Report Q1 2026 Earnings - National Today
Beta Bionics to discuss Q1 results April 21 after market close - Stock Titan
Beta Bionics, Inc. (NASDAQ:BBNX) Short Interest Update - MarketBeat
Beta Bionics (NASDAQ:BBNX) Downgraded to "Sell" Rating by Wall Street Zen - MarketBeat
BBNX SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics - GuruFocus
Aug Selloffs: Can Beta Bionics Inc grow without external funding2026 Volatility Report & AI Enhanced Trading Alerts - baoquankhu1.vn
Insider Buy: Does Beta Bionics Inc have a competitive edge2026 Selloffs & Low Risk Growth Stock Ideas - baoquankhu1.vn
[SCHEDULE 13G/A] Beta... - Stock Titan
BBNX SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics - GlobeNewswire
Lake Street Maintains Beta Bionics(BBNX.US) With Buy Rating, Maintains Target Price $20 - Moomoo
Shorts Report: Can Beta Bionics Inc deliver alphaMarket Activity Summary & High Conviction Buy Zone Picks - baoquankhu1.vn
Inflation Data: Is Beta Bionics Inc a top pick in the sectorInsider Selling & Daily Profit Focused Screening - baoquankhu1.vn
Beta Bionics (NASDAQ:BBNX) Upgraded by Wall Street Zen to "Hold" Rating - marketbeat.com
Faruqi & Faruqi, LLP Continues Investigation of Potential Securities Claims Against Bionics (BBNX) - marketscreener.com
ONGOING INVESTIGATION NOTICE: Faruqi & Faruqi, LLP - GlobeNewswire
Will Beta Bionics, Inc. (BBNX) report negative earnings next week? What you should know - MSN
Beta Bionics Insider Sells Over $63,000 in Stock - National Today
SHAREHOLDER INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Continues Investigation of Potential Securities Claims Against Bionics (NASDAQ: BBNX) - PR Newswire
Granahan Investment Management Invests $1.7M in Beta Bionics - National Today
Top Beta Bionics Executives Quietly Cash Out in Latest Insider Moves - TipRanks
Mark Hopman Sells 2,061 Shares of Beta Bionics (NASDAQ:BBNX) Stock - MarketBeat
Beta Bionics Inc Stock (BBNX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.74%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):